Nyxoah (NYXH) Interest Expenses (2025 - 2026)

Nyxoah's quarterly Interest Expenses came in at -$2383.6 in Q1 2026, up 46.58% year-on-year from -$1626.2 in Q1 2025, and up 46.58% quarter-over-quarter from -$4462.1 in Q1 2025.

Nyxoah has reported Interest Expenses for 2 years, with the latest figure at -$2383.6 in Q1 2026.

  • For the quarter ending Q1 2026, Interest Expenses rose 46.58% year-over-year to -$2383.6; the trailing twelve-month figure through Mar 2026 stood at -$6845.7 (down 53.42% YoY), and the FY2025 full-year result was $13.4 million, up 147.08% from the prior year.
  • Interest Expenses for Q1 2026 stood at -$2383.6, up from -$4462.1 in the prior quarter.
  • The five-year high for Interest Expenses was -$2383.6 in Q1 2026, with the low at -$4462.1 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 149.00 Mn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 1.90 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 22.40 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 16.94 Mn
10 Nyxoah 1,248.49 1,248.49 4.26 Mn -2,383.64

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2,383.64
Mar 31, 2026 -2,383.64
Mar 31, 2025 -4,462.09
Mar 31, 2025 -4,462.09